Weekly Jobless Claims Surprise as Year Winds Down
The U.S. Department of Labor released the weekly jobless claims a day early this week due to the New Year holiday.
All Work
Chris Lange
New Biotech ETF Hits the Market
The ALPS Medical Breakthroughs ETF debuted on the market Wednesday and is focused on research and development opportunities in biotechnology and pharmaceutical industries.
Can Civeo Weather the Storm of Low Oil?
Civeo has announced that due to the fall in oil prices it has cut its 2015 guidance and suspended its dividend.
Can Activist Fund Corvex Save American Realty?
The average investor might not view American Realty Capital Properties as an attractive investment. But one activist investor would say otherwise.
Will the Whole Foods Turnaround Outperform in 2015?
Whole Foods Market appears to have been on Santa’s nice list, as its shares have done very well in the company’s fiscal first quarter.
Flex Pharma Files for IPO
Flex Pharma Inc. has filed with the Securities and Exchange Commission (SEC) for its initial public offering.
Shake Shack Files for IPO
Shake Shack has filed with the Securities and Exchange Commission (SEC) for its initial public offering.
Can Carl Icahn Force Manitowoc to Concede to Activist Pressure?
The year is almost over and Carl Icahn is still making his activist investor moves. His most recent acquisition was a stake in Manitowoc.
Is Gilead Already Coming Back Into Favor?
Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the doghouse?
Has the Santa Rally Already Eaten Too Much Into 2015 Price Targets?
As we draw closer to ringing in the New Year, analysts are already looking ahead to predict what the markets will do.
5 Cheapest DJIA Stocks for 2015
24/7 Wall St. has compiled a group of the five cheapest Dow Jones Industrial Average stocks, based on earnings expected in 2015.
Weekly Jobless Claims Hit by Santa Rally
The U.S. Department of Labor weekly jobless claims report showed fewer claims than expected.
Sol-Wind Files for IPO
Sol-Wind Renewable Power has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering.
More Proof That Patents Worth Millions (or Billions!)
RPX has announced that a subsidiary will purchase the patent assets of Rockstar Consortium.
Are Online Holiday Sales Up Enough?
So far, $48.3 billion has been spent online in the United States, according to comScore, a 15% gain from a year ago.
Analysts Predict Big Value Trap for Gilead Investors
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
Personal Income and Spending: Par for the Course
The U.S. Department of Commerce has released the numbers for personal income and spending for the month of November.
Durable Goods Not Even in Same Ballpark as GDP
The third-quarter gross domestic product may have blown estimates out of the water, but the more recent durable goods report looked awful.
Have NASDAQ-100 Rebalance Winners Rallied Too Much?
NASDAQ OMX Group has announced the results of the annual reranking of the NASDAQ-100, and three companies were added to the index.
What the AbbVie and Express Script Deal Means for Gilead
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.